Explore BEYOND.
Leave nothing unseen.
Ten63 is pushing the
boundaries of computational drug discovery to design first and best-in-class therapeutics with enhanced durability against previously
undruggable targets.
Our BEYOND platform
allow us to design potent chemistry against the hardest targets by searching previously unexplored, drug-like, synthetically accessible
chemical space.
We built BEYOND, our proprietary drug discovery engine that combines physics and AI in hyper-efficient search algorithms, to pursue validated biological targets that exceed the reach of conventional therapeutic research.
Leveraging BEYOND, we look at 19,290,123 compounds per second, or roughly the same number of compounds explored experimentally in the history of humanity.
Our hyper-efficient search algorithms can evaluate complex atomic interactions in 3D space with six continuous degrees of freedom, at unprecedented speed and accuracy, allowing us to find solutions no other method can find. That is what makes Ten63 special.
BEYOND is pioneering a new generation of drug discovery.
Greatest
Medical
Need.
Armed with BEYOND we can overcome challenges in chemistry, to relentlessly pursue the most impactful biology, for the benefit of patients.
At Ten63 we are fiercely focused on progressing our innovative pipeline of previously intractable but highly validated biological targets in oncology.
Beyond exceptional leadership.
We’ve assembled a world-class team of discovery scientists, research pioneers, and renowned key opinion leaders.
Collectively, our leadership team has amassed a portfolio of significant accomplishments.
We’ve assembled a world-class team of discovery scientists, research pioneers, and renowned key opinion leaders.